findmyKOL
Clinical trialNCT00662116TerminatedPhase 2Interventional

Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I)

SponsorSynvista Therapeutics, IncEnrollment160Diastolic Heart Failure
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Facility name not stated

    Birmingham, Alabama, United States

  • Facility name not stated

    Huntsville, Alabama, United States

  • Facility name not stated

    Mobile, Alabama, United States

  • Facility name not stated

    Anaheim, California, United States

  • Facility name not stated

    Bakersfield, California, United States

  • Facility name not stated

    La Jolla, California, United States

  • Facility name not stated

    Roseville, California, United States

  • Facility name not stated

    Jacksonville, Florida, United States

  • Facility name not stated

    Miami, Florida, United States

  • Facility name not stated

    St. Petersburg, Florida, United States

  • Facility name not stated

    Covington, Georgia, United States

  • Facility name not stated

    Indianapolis, Indiana, United States

  • Facility name not stated

    Louisville, Kentucky, United States

  • Facility name not stated

    Auburn, Maine, United States

  • Facility name not stated

    South Portland, Maine, United States

  • Facility name not stated

    Ayer, Massachusetts, United States

  • Facility name not stated

    Lincoln, Nebraska, United States

  • Facility name not stated

    Ridgewood, New Jersey, United States

  • Facility name not stated

    Albany, New York, United States

  • Facility name not stated

    Stony Brook, New York, United States

  • Facility name not stated

    Winston-Salem, North Carolina, United States

  • Facility name not stated

    Cincinnati, Ohio, United States

  • Facility name not stated

    Dayton, Ohio, United States

  • Facility name not stated

    Fairfield, Ohio, United States

  • Facility name not stated

    Sandusky, Ohio, United States

  • Facility name not stated

    Oklahoma City, Oklahoma, United States

  • Facility name not stated

    Charleston, South Carolina, United States

  • Facility name not stated

    Germantown, Tennessee, United States

  • Facility name not stated

    Lackland Airforce Base, Texas, United States

  • Facility name not stated

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2008
Primary completion
31 Oct 2009
Completion
31 Dec 2009
Last update posted
30 Jan 2009
Registered enrollment
160
Registry id
NCT00662116

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.